Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway-Reference-Cited by-同舟云学术

Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway

Published:2015-11-11 Issue:3 Volume:7 Page:2532-2544
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wang Tingting¹,Seah Serena¹,Loh Xinyi¹,Chan Ching-Wan²,Hartman Mikael²,Goh Boon-Cher¹³,Lee Soo-Chin¹³

Affiliation:

1. Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore

2. Department of Surgery, National University Cancer Institute, National University Health System, Singapore, Singapore

3. Department of Haematology and Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Statins on Markers of Breast Cancer Proliferation and Apoptosis in Women with In Situ or Early-Stage Invasive Breast Cancer;International Journal of Molecular Sciences;2024-09-04

2. Peptides as modulators of FPPS enzyme: a multifaceted evaluation from the design to the mechanism of action;European Journal of Medicinal Chemistry;2024-09

3. Regulatory effects of statins on Akt signaling for prevention of cancers;Cellular Signalling;2024-08

4. Nano-assemblies overcome cancer multidrug resistance for effectively synergistic chemo-immuno-oncotherapy;Chemical Engineering Journal;2024-06

5. Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression;Nature Communications;2024-05-30